KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Preferred Shares Issued: 2020

Historic Preferred Shares Issued for AbCellera Biologics (ABCL) over the last 1 years, with Dec 2020 value amounting to -$1,000.

  • AbCellera Biologics' Preferred Shares Issued was N/A to -$1,000 in Q4 2020 from the same period last year, while for Dec 2020 it was $74.7 million, marking a year-over-year change of. This contributed to the annual value of $74.7 million for FY2020, which is 678845.45% up from last year.
  • According to the latest figures from Q4 2020, AbCellera Biologics' Preferred Shares Issued is -$1,000, which was up 94.74% from -$19,000 recorded in Q3 2020.
  • AbCellera Biologics' Preferred Shares Issued's 5-year high stood at $74.7 million during Q1 2020, with a 5-year trough of -$19,000 in Q3 2020.
  • Its 1-year average for Preferred Shares Issued is $18.7 million, with a median of $9,500 in 2020.